Tirzepatide is a prescription medicine. That single fact settles most of the question. There is no route to it that skips a licensed clinician, and any offer that suggests otherwise is telling you something important about the seller.
Important safety information. Tirzepatide is the active ingredient in Mounjaro and Zepbound, which are FDA-approved prescription medicines from Eli Lilly and Company. These branded medicines carry a boxed warning about the risk of thyroid C-cell tumors. They should not be used by people with a personal or family history of medullary thyroid carcinoma, or by people with Multiple Endocrine Neoplasia syndrome type 2. Serious risks can include pancreatitis, gallbladder problems, acute kidney injury, severe stomach and intestinal reactions, serious allergic reactions, low blood sugar when taken with certain other diabetes medicines, and diabetic retinopathy complications. Read the official Prescribing Information and Medication Guide for each one: Mounjaro and Zepbound.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Step one: a clinical evaluation
Everything starts here, whether the visit is in person or by telehealth. A clinician reviews your health history, current conditions, medicines you already take, allergies, and your goals. Some histories rule this class of medicine out entirely, which is why the boxed warning and the contraindications above are not fine print.
Bring a current medicine list including supplements, a summary of past and present conditions, any recent laboratory results you have, and your insurance card if you have one.
Expect real questions, and expect the possibility of a no. A clinician who prescribes without evaluating is not doing the job that makes the prescription legal or safe.
Step two: a decision that may not be a prescription
A clinician may decide that a different approach fits you better, that something should be checked first, or that this class is not appropriate for you at all.
This is a normal outcome and not a failed visit. The point of the evaluation is to reach the right answer for your situation, and no website can do that for you.
If a prescription is written, the clinician chooses the product, strength, quantity, and instructions. Those choices belong to the clinician and the label, not to a preference set by a buyer.
Step three: the pharmacy
The prescription goes to a licensed pharmacy, which dispenses what was written and bills for that fill. If insurance is involved, the pharmacy runs the claim and the plan applies its own rules.
Plans frequently require prior authorization for this class, and may apply quantity limits, step therapy, or a preferred pharmacy. That paperwork travels between the clinician's office and the plan, and it takes time. Ask at the visit whether prior authorization is likely so the wait does not surprise you.
Approval and payment are determined by the plan, not by any clinic. A benefits estimate is not a decision.
Step four: follow-up
Ongoing care is part of the medicine, not an add-on. Follow-up visits exist so a clinician can check how you are doing, review side effects, and adjust the plan.
Read the Medication Guide that comes with the prescription, and keep the pharmacist's number handy. If something concerns you between visits, call the clinician rather than searching for an answer.
The approved route and the compounded route are not the same route
FDA-approved tirzepatide products are finished drug products reviewed and approved by FDA, with an official label and Prescribing Information linked at the top of this page.
Compounded tirzepatide is prepared by a pharmacy instead.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality.
Compounded tirzepatide is not Zepbound, not Mounjaro, not Ozempic and not Wegovy. It is not a generic version of any approved drug, and it is not interchangeable with one. FDA's overview of human drug compounding describes the category and what it does and does not involve.
Compounded tirzepatide may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, and only from a state-licensed pharmacy. There is no order-now path to it.
If you are considering this route, ask which state-licensed pharmacy dispenses it, which state licenses that pharmacy, and how to reach the pharmacist directly. A seller who cannot answer those three questions plainly has told you enough.
Warning signs worth walking away from
A site that ships without any clinician evaluation. A site that will not name the dispensing pharmacy. A product offered under a brand name it does not hold. Claims that a preparation is a generic of an approved product. Pressure to buy today. Prices quoted as final before anyone has evaluated you.
Personal imports and unlicensed resellers carry a further problem: nobody is accountable for what is in the vial. The FDA page above is a useful starting point for understanding why that distinction exists.
What Body Good actually does
Body Good is a clinical service. It provides evaluation, ongoing care, and support, and its prices are service fees for the program described at intake. Those fees are not the price of medication and are not a quote for any individual. Eligibility is determined by a clinician.
The cost of medication is separate and is not included in a Body Good service fee. A dispensing pharmacy bills for what it fills.
Body Good provides coverage support, which means help checking benefits and preparing paperwork a plan requests. It does not determine what a plan approves or pays.
This site is an information and pricing overview only. It takes no payment, collects no health information, and runs no intake form. Intake happens on joinbodygood.com.
Frequently asked questions
Can I get tirzepatide without seeing a clinician?
No. It is a prescription medicine, and a prescription requires a licensed clinician who has evaluated you. Telehealth changes where the visit happens, not whether it happens.
How long does the process take?
It depends on scheduling, whether laboratory work is ordered, and whether your plan requires prior authorization. Prior authorization is the step that most often adds time, so ask about it early.
What if a clinician decides it is not right for me?
That is a real and valid outcome, and it means the evaluation worked. Ask what the reason was and what alternatives make sense for you. Begin Body Good's clinical intake if you would like a clinician to review your situation.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.